Jiangsu Nhwa Pharmaceutical Co Ltd (002262) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.053x

Based on the latest financial reports, Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a cash flow conversion efficiency ratio of 0.053x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥425.83 Million ≈ $62.31 Million USD) by net assets (CN¥8.08 Billion ≈ $1.18 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Jiangsu Nhwa Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Jiangsu Nhwa Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Jiangsu Nhwa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002262 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Jiangsu Nhwa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Nhwa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fujian Longking Co Ltd SHG:600388	0.076x
Glory View Technology Co. Ltd. A SHE:301396	N/A
International Game Technology PLC NYSE:IGT	0.154x
TELEPERFORMANCE SE ADR F:RCF0	N/A
Berner Kantonalbank AG SW:BEKN	0.136x
Energix Renewable Energies Ltd TA:ENRG	0.002x
Jiangxi Jovo Energy Co. Ltd SHG:605090	-0.003x
Denali Therapeutics Inc NASDAQ:DNLI	-0.142x

Annual Cash Flow Conversion Efficiency for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Jiangsu Nhwa Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.03 Billion ≈ $1.17 Billion	CN¥1.08 Billion ≈ $157.80 Million	0.134x	+6.65%
2024-12-31	CN¥7.27 Billion ≈ $1.06 Billion	CN¥916.13 Million ≈ $134.06 Million	0.126x	-19.93%
2023-12-31	CN¥6.41 Billion ≈ $938.00 Million	CN¥1.01 Billion ≈ $147.55 Million	0.157x	+2.01%
2022-12-31	CN¥5.58 Billion ≈ $817.07 Million	CN¥861.02 Million ≈ $125.99 Million	0.154x	+7.85%
2021-12-31	CN¥4.90 Billion ≈ $717.57 Million	CN¥701.12 Million ≈ $102.60 Million	0.143x	-52.98%
2020-12-31	CN¥4.11 Billion ≈ $600.76 Million	CN¥1.25 Billion ≈ $182.67 Million	0.304x	+258.24%
2019-12-31	CN¥3.60 Billion ≈ $527.50 Million	CN¥305.97 Million ≈ $44.77 Million	0.085x	-37.93%
2018-12-31	CN¥2.96 Billion ≈ $432.87 Million	CN¥404.52 Million ≈ $59.19 Million	0.137x	-25.59%
2017-12-31	CN¥2.46 Billion ≈ $360.17 Million	CN¥452.35 Million ≈ $66.19 Million	0.184x	+40.84%
2016-12-31	CN¥2.12 Billion ≈ $310.80 Million	CN¥277.14 Million ≈ $40.55 Million	0.130x	+16.75%
2015-12-31	CN¥1.83 Billion ≈ $267.39 Million	CN¥204.24 Million ≈ $29.89 Million	0.112x	-26.13%
2014-12-31	CN¥1.06 Billion ≈ $154.97 Million	CN¥160.24 Million ≈ $23.45 Million	0.151x	-34.89%
2013-12-31	CN¥836.21 Million ≈ $122.36 Million	CN¥194.33 Million ≈ $28.44 Million	0.232x	+2.88%
2012-12-31	CN¥682.44 Million ≈ $99.86 Million	CN¥154.16 Million ≈ $22.56 Million	0.226x	+54.92%
2011-12-31	CN¥556.01 Million ≈ $81.36 Million	CN¥81.08 Million ≈ $11.86 Million	0.146x	+9.15%
2010-12-31	CN¥462.56 Million ≈ $67.69 Million	CN¥61.79 Million ≈ $9.04 Million	0.134x	-13.66%
2009-12-31	CN¥396.00 Million ≈ $57.95 Million	CN¥61.27 Million ≈ $8.97 Million	0.155x	+14.38%
2008-12-31	CN¥343.75 Million ≈ $50.30 Million	CN¥46.50 Million ≈ $6.80 Million	0.135x	-57.54%
2007-12-31	CN¥152.39 Million ≈ $22.30 Million	CN¥48.55 Million ≈ $7.10 Million	0.319x	+26.12%
2006-12-31	CN¥122.67 Million ≈ $17.95 Million	CN¥30.99 Million ≈ $4.53 Million	0.253x	+259.29%
2005-12-31	CN¥125.74 Million ≈ $18.40 Million	CN¥8.84 Million ≈ $1.29 Million	0.070x	--

About Jiangsu Nhwa Pharmaceutical Co Ltd

SHE:002262 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.30 Billion

CN¥22.58 Billion CNY

Market Cap Rank

#4589 Global

#733 in China

Share Price

CN¥22.23

Change (1 day)

+0.59%

52-Week Range

CN¥18.23 - CN¥28.92

All Time High

CN¥31.19